Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warren E Rose

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
Stem Cell Research & Therapy|July 23, 2017
Minocycline modulates NFκB phosphorylation and enhances antimicrobial activity against Staphylococcus aureus in mesenchymal stromal/stem cellsAlberto Daniel Guerra, Warren E Rose, Peiman Hematti, et al.
Antimicrobial Agents and Chemotherapy|August 11, 2010
Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilmJorge Parra-Ruiz, Celine Vidaillac, Warren E Rose, et al.
The Journal of Antimicrobial Chemotherapy|February 12, 2008
Teicoplanin pharmacodynamics in reference to the accessory gene regulator (agr) in Staphylococcus aureus using an in vitro pharmacodynamic modelWarren E Rose, Glenn W Kaatz, George Sakoulas, et al.
Open Forum Infectious Diseases|December 2, 2025
Telehealth: The Way for Efficient, Comprehensive, and Equitable Antimicrobial Stewardship in the US Healthcare SystemCourtney J Baus, Shivani Patel, Alexander J Lepak, et al.
Diagnostic Microbiology and Infectious Disease|July 23, 2019
Antimicrobial stewardship during a time of rapid antimicrobial development: Potential impact on industry for future investmentLucas T Schulz, Seok Yeong Kim, Alyssa Hartsell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Dissecting Out the Direct Impacts of Large-Scale Antimicrobial Stewardship Interventions on Clinical Outcomes: Can Confounding Be Overcome?Thomas J Dilworth, Warren E Rose, George Sakoulas, et al.
Pharmacotherapy|November 10, 2017
Multiple-Dose Oritavancin Evaluation in a Retrospective Cohort of Patients with Complicated InfectionsLucas T Schulz, Emily Dworkin, Jennifer Dela-Pena, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2013
β-Lactam antibiotics targeting PBP1 selectively enhance daptomycin activity against methicillin-resistant Staphylococcus aureusAndrew D Berti, George Sakoulas, Victor Nizet, et al.
Antimicrobial Agents and Chemotherapy|May 8, 2013
Relationship of in vitro synergy and treatment outcome with daptomycin plus rifampin in patients with invasive methicillin-resistant Staphylococcus aureus infectionsWarren E Rose, Andrew D Berti, Jacob B Hatch, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2012
Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant Enterococcus faecium from renal transplant patients with infected urinary stentsJillian L Descourouez, Margaret R Jorgenson, Justine E Wergin, et al.
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
Stem Cell Research & Therapy|July 23, 2017
Minocycline modulates NFκB phosphorylation and enhances antimicrobial activity against Staphylococcus aureus in mesenchymal stromal/stem cellsAlberto Daniel Guerra, Warren E Rose, Peiman Hematti, et al.
Antimicrobial Agents and Chemotherapy|August 11, 2010
Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilmJorge Parra-Ruiz, Celine Vidaillac, Warren E Rose, et al.
The Journal of Antimicrobial Chemotherapy|February 12, 2008
Teicoplanin pharmacodynamics in reference to the accessory gene regulator (agr) in Staphylococcus aureus using an in vitro pharmacodynamic modelWarren E Rose, Glenn W Kaatz, George Sakoulas, et al.
Open Forum Infectious Diseases|December 2, 2025
Telehealth: The Way for Efficient, Comprehensive, and Equitable Antimicrobial Stewardship in the US Healthcare SystemCourtney J Baus, Shivani Patel, Alexander J Lepak, et al.
Diagnostic Microbiology and Infectious Disease|July 23, 2019
Antimicrobial stewardship during a time of rapid antimicrobial development: Potential impact on industry for future investmentLucas T Schulz, Seok Yeong Kim, Alyssa Hartsell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Dissecting Out the Direct Impacts of Large-Scale Antimicrobial Stewardship Interventions on Clinical Outcomes: Can Confounding Be Overcome?Thomas J Dilworth, Warren E Rose, George Sakoulas, et al.
Pharmacotherapy|November 10, 2017
Multiple-Dose Oritavancin Evaluation in a Retrospective Cohort of Patients with Complicated InfectionsLucas T Schulz, Emily Dworkin, Jennifer Dela-Pena, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2013
β-Lactam antibiotics targeting PBP1 selectively enhance daptomycin activity against methicillin-resistant Staphylococcus aureusAndrew D Berti, George Sakoulas, Victor Nizet, et al.
Antimicrobial Agents and Chemotherapy|May 8, 2013
Relationship of in vitro synergy and treatment outcome with daptomycin plus rifampin in patients with invasive methicillin-resistant Staphylococcus aureus infectionsWarren E Rose, Andrew D Berti, Jacob B Hatch, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2012
Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant Enterococcus faecium from renal transplant patients with infected urinary stentsJillian L Descourouez, Margaret R Jorgenson, Justine E Wergin, et al.
Pageof 11